Human cathelicidin antimicrobial peptide for immune research.
LL-37 is the only human cathelicidin, a 37-residue cationic peptide central to innate-immune defense and wound-healing research.
Disrupts microbial membranes, modulates TLR signaling, and recruits/activates immune cells.
Peptide engages target receptor with high affinity.
Downstream intracellular pathways activate.
Gene expression and protein synthesis shift.
Measurable change in the studied biomarker.
Reviewed antimicrobial, immunomodulatory and barrier roles of LL-37.
Catalogued multifunctional roles spanning innate defense and inflammation.
Identified LL-37 expression in wound edges and tested in keratinocyte migration.
Demonstrated LL-37 required for normal re-epithelialization of human wounds.
Reviewed cathelicidin family with focus on LL-37 structure-function.
Established membrane-disruption and immunomodulatory mechanisms.
Lyophilized -20°C.
Strictly for in-vitro laboratory and research investigations.
Not approved for diagnostic, therapeutic, or veterinary application.
Handling restricted to licensed researchers and laboratory staff.
Warning — LL-37 is supplied solely for legitimate laboratory research. Any administration to humans or animals is strictly prohibited and may violate federal, state, or local law. By purchasing, the researcher accepts full responsibility for safe handling, storage, and lawful use.
